Page last updated: 2024-11-04

alpha-pyrone-4,6-dicarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpha-pyrone-4,6-dicarboxylic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-oxo-2H-pyran-4,6-dicarboxylate : A dicarboxylic acid dianion obtained via deprotonation of both carboxy groups of 2-oxo-2H-pyran-4,6-dicarboxylic acid; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID22483467
CHEBI ID58304
MeSH IDM0082135

Synonyms (10)

Synonym
2-oxo-2h-pyran-4,6-dicarboxylate dianion
CHEBI:58304
2-oxo-2h-pyran-4,6-dicarboxylate
2-pyrone-4,6-dicarboxylic acid
alpha-pyrone-4,6-dicarboxylate
alpha-pyrone-4,6-dicarboxylic acid
2-pyrone-4,6-dicarboxylate
6-oxo-6h-​
Q27125684
6-oxopyran-2,4-dicarboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dicarboxylic acid dianionA carboxylic acid dianion obtained by deprotonation of both carboxy groups of any dicarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
methylgallate degradation1122
3-chlorobenzoate degradation II (via protocatechuate)512
3,4-dichlorobenzoate degradation48
syringate degradation1224
protocatechuate degradation I (meta-cleavage pathway)1529
superpathway of vanillin and vanillate degradation827
gallate degradation II312

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's0 (0.00)18.2507
2000's4 (23.53)29.6817
2010's6 (35.29)24.3611
2020's6 (35.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]